OverviewSuggest Edit

Digirad Corporation is a provider of diagnostic solutions. The Company's business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers.
TypePublic
Founded1985
HQSuwanee, US
Websitedigirad.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Dec 2018)452(-12%)
Job Openings17
Revenue (FY, 2018)$104.2 M(-11%)
Share Price (Jun 2019)$6.6 (+6%)

Key People/Management at Digirad

Matt Molchan

Matt Molchan

Chief Executive Officer, Interim CFO, and Director, Digirad Corporation
Martin B. Shirley

Martin B. Shirley

President, DIS
Mickey King

Mickey King

Executive Chairman, Digirad Imaging Solutions
Show more

Digirad Office Locations

Digirad has an office in Suwanee
Suwanee, US (HQ)
1048 Industrial Ct
Show all (1)

Digirad Financials and Metrics

Digirad Revenue

Embed Graph
View revenue for all periods
Digirad's revenue was reported to be $104.18 m in FY, 2018
USD

Revenue (Q2, 2019)

23.3m

Gross profit (Q2, 2019)

2.5m

Gross profit margin (Q2, 2019), %

10.7%

Net income (Q2, 2019)

(1.2m)

EBIT (Q2, 2019)

(1.1m)

Market capitalization (10-Jun-2019)

13.5m

Closing stock price (10-Jun-2019)

6.6

Cash (30-Jun-2019)

864.0k

EV

27.9m
Digirad's current market capitalization is $13.5 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

49.4m55.6m60.8m125.5m118.3m104.2m

Revenue growth, %

13%9%106%

Cost of goods sold

35.3m39.0m42.9m89.7m89.9m85.9m

Gross profit

14.1m16.6m17.9m35.8m28.4m18.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

12.4m13.0m14.6m13.9m13.8m15.5m15.9m31.2m32.1m31.1m29.1m29.8m28.6m25.5m27.1m25.7m21.6m23.3m

Cost of goods sold

8.6m9.6m10.1m9.5m10.2m10.8m11.1m22.1m22.3m22.8m22.0m22.8m21.9m20.9m21.5m21.3m19.9m20.8m

Gross profit

3.8m3.4m4.5m4.4m3.6m4.8m4.8m9.1m9.8m8.3m7.1m7.0m6.6m4.6m5.6m4.4m1.7m2.5m

Gross profit Margin, %

31%26%31%32%26%31%30%29%30%27%24%24%23%18%21%17%8%11%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

18.7m14.1m15.9m2.2m1.9m1.5m

Accounts Receivable

5.4m6.0m7.3m14.5m15.9m12.6m

Inventories

3.9m4.4m6.0m5.5m5.4m

Current Assets

36.7m33.0m31.7m27.1m25.6m21.2m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

17.6m9.5m11.6m12.8m13.9m14.9m13.9m7.2m3.3m2.4m1.9m1.8m1.1m1.0m1.4m963.0k797.0k864.0k

Accounts Receivable

6.1m7.3m6.2m6.6m7.1m7.3m8.3m13.8m14.1m13.6m13.6m13.6m14.0m12.8m12.6m13.5m13.4m12.8m

Inventories

4.4m3.8m3.5m3.5m3.7m4.0m4.3m4.8m5.8m5.9m5.9m5.9m5.9m5.8m6.0m5.9m5.5m5.8m

Current Assets

37.2m31.7m32.0m33.2m33.0m33.8m34.7m32.2m29.1m27.1m26.6m23.8m23.3m22.2m22.5m22.5m21.3m21.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

264.0k2.5m21.6m14.3m(35.7m)736.0k

Depreciation and Amortization

1.9m356.0k2.4m9.9m11.1m8.7m

Inventories

1.1m300.0k(811.0k)(1.3m)409.0k(12.0k)

Accounts Payable

(935.0k)776.0k(203.0k)439.0k(1.2m)25.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(523.0k)(148.0k)675.0k1.7m745.0k1.8m21.0m11.6m12.6m12.3m(2.1m)(4.8m)(13.7m)4.1m3.8m2.3m(1.7m)(2.9m)

Depreciation and Amortization

1.4m453.0k944.0k1.4m105.0k1.1m1.8m2.5m4.8m7.3m2.6m5.2m7.7m2.3m4.6m6.7m1.8m3.7m

Inventories

694.0k293.0k444.0k406.0k(362.0k)(730.0k)(63.0k)(1.1m)(1.3m)45.0k157.0k7.0k(177.0k)(463.0k)(355.0k)8.0k(290.0k)

Accounts Payable

167.0k449.0k634.0k1.1m1.2m1.2m(871.0k)(669.0k)431.0k(322.0k)(860.0k)(940.0k)21.0k(73.0k)(706.0k)(664.0k)(694.0k)
USDY, 2019

EV/EBIT

-21.3 x

EV/CFO

66.5 x

Financial Leverage

2.5 x
Show all financial metrics

Digirad Online and Social Media Presence

Embed Graph

Digirad News and Updates

Digirad Announces Listing and Trading of Preferred Stock on Nasdaq Global Market Under Symbol “DRADP”

SUWANEE, Ga., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “Company”) announced that its newly issued 10.0% Series A Cumulative Perpetual Preferred Stock, with a stated value and liquidation preference of $10 per share (the “Digirad Preferred Stock”), has…

Digirad Corporation to Release 2019 Second Quarter Financial Results on August 6, 2019

SUWANEE, Ga., July 24, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) will release financial results for its second quarter ended June 30, 2019 before the market opens on Tuesday, August 6, 2019.

Digirad Corporation Announces Execution of Merger Agreement to Acquire ATRM Holdings, Inc. to Launch Holding Company Structure

Plans to Create Preferred Stock which is Intended to be Listed on Nasdaq

Digirad Corporation Announces Reverse Stock Split

1-for-10 Reverse Stock Split Effective June 4, 2019 for Trading June 5, 2019 1-for-10 Reverse Stock Split Effective June 4, 2019 for Trading June 5, 2019

Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2019

SUWANEE, Ga., May 03, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) reported today its financial results for the first quarter ended March 31, 2019.

Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2018

SUWANEE, Ga., March 01, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) reported today its financial results for the fourth quarter and twelve months ended December 31, 2018.
Show more

Digirad Blogs

CT, MR and the Current State of Technology for Cardiac Imaging

Technology and the modalities that drive diagnostic cardiology continue to see innovation and development. New technologies and advancements in cardiac imaging will have a direct effect on both cardiologists and patients as they move mainstream. In this post, we’ll look at what is happening with car…

Enhancing the Pediatric Patient Experience with Point-of-Care Imaging

If you work in children’s healthcare – especially within radiology and nuclear imaging department of the hospital – you know from personal experience that pediatric patients can be anxious around large machines, new people, and even the clinical environments of the radiology department itself. You’v…

New Studies Highlight Innovations in Drug-Eluting Stent Research

The recently released Stent Market Report highlights steady growth happening in the stent industry. The global stent market is expected to reach an estimated $10.8 billion by 2024, with a CAGR of 3.3% from 2019 to 2024. This growth is largely driven by increasing interventional cardiology and periph…

A Look Back at News from SNMMI 2019

The SNMMI 2019 Annual Meeting wrapped up last week and proved to be an informative and eventful event. The Digirad team was on hand during the show and enjoyed connecting with colleagues and customers in Anaheim, California. Here are some highlights from SNMMI 2019. Image of the Year & the Futur…

How Hospitals Can Reduce Risk By Limiting Patient Transportation for Imaging

Transporting patients for any reason, especially the critically ill, is a risky prospect. Yet there are a number of reasons why a hospital may need to move a patient. Imaging is just one of those, with patients being moved to different parts of the hospital or even off premises where needed imaging …

Key differences between a CZT gamma camera and a CsI imager

Signal detectors are a key component of any medical imaging technology. Many gamma cameras still in use today utilize technology that is more than 50 years old – the Anger-based analog technology. However, more modern options are available with solid state technology. Solid state comes in two main f…
Show more

Digirad Frequently Asked Questions

  • When was Digirad founded?

    Digirad was founded in 1985.

  • Who are Digirad key executives?

    Digirad's key executives are Matt Molchan, Martin B. Shirley and Mickey King.

  • How many employees does Digirad have?

    Digirad has 452 employees.

  • What is Digirad revenue?

    Latest Digirad annual revenue is $104.2 m.

  • What is Digirad revenue per employee?

    Latest Digirad revenue per employee is $230.5 k.

  • Who are Digirad competitors?

    Competitors of Digirad include Arise Healthcare, Sectra and IZI Medical Products.

  • Where is Digirad headquarters?

    Digirad headquarters is located at 1048 Industrial Ct, Suwanee.

  • Where are Digirad offices?

    Digirad has an office in Suwanee.

  • How many offices does Digirad have?

    Digirad has 1 office.